Cubit Diagnostics SAFE

Cubit Diagnostics — Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

www.cubitdx.com LinkedIn3 foundersBiotechnology, Healthcare, Diagnostics

Round summary

Cubit Diagnostics has secured an undisclosed amount in a new SAFE financing round, marking its first external funding. The capital will advance the design freeze of its molecular CT/NG/TV assay, targeting Q4 2026, and bolster its immunoassay program. This funding is poised to support the company's progression towards a clinical study in H1 2027.

Investors (0)

No investors disclosed.

Cubit Diagnostics's other rounds

Cubit Diagnostics

Grant · Sep 30, 2025

$307K

Cubit Diagnostics

Grant · Dec 2, 2024

$3M

Loading investment round...